Wendy future of retail top

Kremers Urban Pharmaceuticals

Lannett cleared to market Nexium generic

Lannett cleared to market Nexium generic

PHILADELPHIA — Lannett Co. has received Food and Drug Administration approval for 20-mg and 40-mg esomeprazole magnesium delayed-release capsules, an antacid. Lannett said its esomeprazole product is a generic version of Nexium delayed-release capsules (20 mg and 40 mg), aka “the purple pill,” from AstraZeneca Pharmaceuticals. A proton pump inhibitor, esomeprazole decreases the amount of acid in

Lannett readies pair of new generics

Lannett readies pair of new generics

PHILADELPHIA — Lannett Co. has received Food and Drug Administration approval for niacin extended-release tablets 500 mg and 1,000 mg and amantadine hydrochloride capsules 100 mg. Lannett said Monday that its niacin product is a generic version of Niaspan ER tablets (500 mg and 1,000 mg) from AbbVie Inc. The medication is indicated to raise

Lannett to pare workforce in restructuring plan

Lannett to pare workforce in restructuring plan

PHILADELPHIA — Lannett Co. has instituted a restructuring plan to streamline operations, sharpen efficiencies and trim costs. Announced this week, the plan is part of the generic drug maker’s efforts to integrate its recently completed acquisition of Kremers Urban Pharmaceuticals Inc. Lannett said actions are already under way and include the closing of Kremers Urban’s

Lannett to buy Kremers Urban for $1.23 billion

Lannett to buy Kremers Urban for $1.23 billion

PHILADELPHIA — Lannett Co. plans to acquire Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic drug subsidiary of UCB S.A., in a $1.23 billion deal. Lannett said late Wednesday that the acquisition will add a diversified commercial product portfolio of 18 products. Kremers Urban currently markets generic products that treat a range of conditions, including

PP_1170x120_10-25-21